Premium
CBD: Can it help people with opioid use disorder?
Publication year - 2019
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30449
Subject(s) - craving , cannabidiol , opioid , anxiety , drug , adverse effect , placebo , medicine , cannabis , psychiatry , psychology , heroin , addiction , pharmacology , anesthesia , alternative medicine , receptor , pathology
Cannabidiol (CBD) has the potential to reduce craving and anxiety in people with opioid use disorder who have been opioid‐free for at least a week, a recent study using Epidiolex, the Food and Drug Administration–approved form of the marijuana‐derived drug, has found. The study compared CBD to placebo in subjects who were exposed to drug‐related and non‐drug‐related cues, and measured craving and anxiety. CBD administration was short‐term (3 days), but beneficial effects lasted 7 days afterward. There were no effects on cognition and no adverse effects.